1. Home
  2. VCEL vs OGN Comparison

VCEL vs OGN Comparison

Compare VCEL & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$46.23

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.50

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCEL
OGN
Founded
1989
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
VCEL
OGN
Price
$46.23
$13.50
Analyst Decision
Strong Buy
Hold
Analyst Count
5
5
Target Price
$57.75
$11.40
AVG Volume (30 Days)
598.5K
2.4M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
0.60%
EPS Growth
60.00
N/A
EPS
N/A
0.55
Revenue
$276,259,000.00
$6,216,000,000.00
Revenue This Year
$19.40
$0.45
Revenue Next Year
$18.24
$1.67
P/E Ratio
N/A
$24.49
Revenue Growth
16.45
N/A
52 Week Low
$28.95
$5.69
52 Week High
$43.57
$13.49

Technical Indicators

Market Signals
Indicator
VCEL
OGN
Relative Strength Index (RSI) 81.81 71.58
Support Level $32.47 $10.05
Resistance Level N/A N/A
Average True Range (ATR) 1.61 0.05
MACD 0.70 -0.08
Stochastic Oscillator 96.76 95.83

Price Performance

Historical Comparison
VCEL
OGN

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: